Company Data
Tyme Technologies Inc.
Ticker
TYME
Current Price
$0.3107
Market Cap
$53.5M
Price Target
Refer to Report
Volume
370
52wk Range
$0.2187 - $0.405
Overview
Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. The company is currently conducting a Phase II trial in prostate cancer.